Halozyme To Host Second Quarter 2017 Financial Results Conference Call

SAN DIEGO, July 10, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the second quarter 2017 on Tues., Aug. 8 at 4:30 p.m. ET/1:30 p.m. PT....